FDA approves Hep C drugs.
D000998:Antiviral Agents / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D012254:Ribavirin / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D012254:Ribavirin